Research
Metabolic adaptation
Endoscopic sleeve gastroplasty (ESG) has demonstrated durable weight loss, favorable safety, and superior cost-effectiveness compared to pharmacotherapy alone.
Practitioners may consider ESG as a viable option for patients seeking effective weight loss.
StrongSupportsmedium confidence
ESG has demonstrated durable weight loss, favorable safety, and superior cost-effectiveness compared to pharmacotherapy alone.
Why this rating
The claim is based on a review of established therapies.
Source
Emerging Trends in Endoscopic Bariatric Therapies: Personalization Through Genomics and Synergistic Pharmacotherapy
Wissam Ghusn et al. · Journal of Clinical Medicine · 2025
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →